Enzo Biochem, Inc. Annual report pursuant to Section 13 and 15(d)

Summary of Significant Accounting Policies (Details) - Schedule of net accounts receivable by segment

Summary of Significant Accounting Policies (Details) - Schedule of net accounts receivable by segment - USD ($) $ in Thousands	Jul. 31, 2021	Jul. 31, 2020
Summary of Significant Accounting Policies (Details) - Schedule of net accounts receivable by segment [Line Items]
Accounts receivable net, current	$ 10,198	$ 9,141
Clinical Labs [Member]
Summary of Significant Accounting Policies (Details) - Schedule of net accounts receivable by segment [Line Items]
Accounts receivable net, current	$ 6,016	$ 6,180
Accounts receivable net, current, percentage	100.00%	100.00%
Life science [Member]
Summary of Significant Accounting Policies (Details) - Schedule of net accounts receivable by segment [Line Items]
Accounts receivable net, current	$ 4,182	$ 2,961
Third party payers [Member] \| Clinical Labs [Member]
Summary of Significant Accounting Policies (Details) - Schedule of net accounts receivable by segment [Line Items]
Accounts receivable net, current	$ 2,195	$ 2,455
Accounts receivable net, current, percentage	36.00%	40.00%
Patient self-pays [Member] \| Clinical Labs [Member]
Summary of Significant Accounting Policies (Details) - Schedule of net accounts receivable by segment [Line Items]
Accounts receivable net, current	$ 2,007	$ 2,044
Accounts receivable net, current, percentage	33.00%	33.00%
Medicare [Member] \| Clinical Labs [Member]
Summary of Significant Accounting Policies (Details) - Schedule of net accounts receivable by segment [Line Items]
Accounts receivable net, current	$ 1,122	$ 884
Accounts receivable net, current, percentage	19.00%	14.00%
Health maintenance organizations [Member] \| Clinical Labs [Member]
Summary of Significant Accounting Policies (Details) - Schedule of net accounts receivable by segment [Line Items]
Accounts receivable net, current	$ 692	$ 797
Accounts receivable net, current, percentage	12.00%	13.00%